Thinking of joining a study?

Register your interest

NCT03270982 | RECRUITING | Degenerative Disease


Comprehensive Segmental Revision System
Sponsor:

Zimmer Biomet

Brief Summary:

Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.

Condition or disease

Degenerative Disease

Oncology

Revision Surgery

Trauma

Rheumatoid Arthritis

Intervention/treatment

Comprehensive SRS Replacement

Detailed Description:

The Purpose of this multi centre clinical data evaluation is to document the performance and clinical outcomes of the Comprehensive Segmental revision System. The data gathered will be collated and used to provide feedback to designing engineers, support marketing efforts, answer potential questions from reimbursement agencies, and will serve as part of Zimmer Biomets Post Market Surveillance. The Comprehensive Segmental Revision System consists of a proximal humeral replacement system (shoulder prosthesis), a distal humeral replacement system (elbow prosthesis) and of a total humeral replacement system (shoulder and elbow prosthesis connected by a humeral coupler). Patient outcomes will be measured by using measurement tools that have been extensively used and referred to in the literature. Specifically, the quickDASH will be used for all cases enrolled in the study. In addition, the Constant and Murley Score may be used for shoulder applications, the Liverpool Elbow Score may be used for elbow applications and the MSTS Score may be used for tumor cases. The study population will be compromised of males and females that are eligible according to the inclusion/exclusion criteria. The study will last for at least ten (10) years from the time of surgery.

Study Type : OBSERVATIONAL
Estimated Enrollment : 105 participants
Official Title : Comprehensive Segmental Revision System
Actual Study Start Date : 2016-04
Estimated Primary Completion Date : 2034-12
Estimated Study Completion Date : 2034-12

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis
  • * Rheumatoid arthritis
  • * Revision where other devices or treatments have failed
  • * Correction of functional deformity
  • * Oncology applications including bone loss due to tumour resection
Exclusion Criteria
  • * Sepsis ( active)
  • * Infection ( active)
  • * Osteomyelitis (active)

Comprehensive Segmental Revision System

Location Details

NCT03270982


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

Canada, New Scotia

Nova Scotia Health Authority

Halifax, Nova Scotia, Canada, He sold it-1796

RECRUITING

Denmark,

Department of Orthopedic Surgery, Rigshospitalet University of Copenhagen

Copenhagen, Denmark,

COMPLETED

United Kingdom, Wales

Royal Gwent Hospital

Newport, Wales, United Kingdom, NP20 2UB

RECRUITING

United Kingdom,

Royal Liverpool University Hospital

Liverpool, United Kingdom,

Loading...